RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Alligator Bioscience Stock

Alligator Bioscience Market capitalization 2024

Alligator Bioscience Market capitalization

550.75 M SEK

Ticker

ATORX.ST

ISIN

SE0000767188

WKN

A2AN1Z

In 2024, Alligator Bioscience's market cap stood at 550.75 M SEK, a 196.05% increase from the 186.03 M SEK market cap in the previous year.

The Alligator Bioscience Market capitalization history

YEARMarket Capitalization (undefined SEK)
20230.36
20220.66
20210.75
20201.15
20191.54
20182.3
20172.35
20162.3
2015-
2014-

Alligator Bioscience Aktienanalyse

What does Alligator Bioscience do?

Alligator Bioscience AB is a biopharmaceutical company based in Lund, Sweden. The company was founded in 2001 and specializes in the development of innovative cancer therapies that harness the body's immune system to fight tumor cells. The company's business model is based on the research, development, and commercialization of biological drugs using highly specialized technologies such as antibody research and immuno-oncology. Alligator Bioscience works closely with leading research institutions and partners in the biotechnology and pharmaceutical industries. Its main focus is on developing antibodies against cancer using its patented technology platforms ALLIGATOR-GOLD® and ALLIGATOR-FAB®. These antibodies are highly effective, safe, and have a low side effect profile. Another important area of Alligator Bioscience's work is immuno-oncology, which involves activating and enhancing the body's own immune system to target and destroy cancer cells. The company has developed a range of innovative drugs in various stages of clinical development. One of its key products is ATOR-1017, a monoclonal antibody that targets the OX40 T-cell receptor and has shown promising results in activating the immune system against cancer in clinical trials. ADC-1013, an antibody targeting the PD-1 receptor, is another promising drug in development for the treatment of various types of cancer. Alligator Bioscience has a diverse portfolio of products and drugs focused on fighting cancer and works closely with research partners and customers to improve the effectiveness and safety of its products for market release. In summary, Alligator Bioscience is a leading company in cancer research and therapy, with an innovative technology platform and highly specialized drugs that have shown promising results. The company is continuously working to develop new and better cancer therapies. Alligator Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Alligator Bioscience's Market Capitalization

Alligator Bioscience's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Alligator Bioscience's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Alligator Bioscience's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Alligator Bioscience’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Alligator Bioscience stock

What is the current Alligator Bioscience market capitalization?

The current market capitalization of Alligator Bioscience is 550.75 M SEK.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Alligator Bioscience.

How has the market capitalization of Alligator Bioscience developed in recent years?

The market capitalization of Alligator Bioscience has increased/decreased by 196.05% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Alligator Bioscience?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Alligator Bioscience?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Alligator Bioscience have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Alligator Bioscience pay?

Over the past 12 months, Alligator Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alligator Bioscience is expected to pay a dividend of 0 SEK.

What is the dividend yield of Alligator Bioscience?

The current dividend yield of Alligator Bioscience is .

When does Alligator Bioscience pay dividends?

Alligator Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Alligator Bioscience?

Alligator Bioscience paid dividends every year for the past 0 years.

What is the dividend of Alligator Bioscience?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Alligator Bioscience located?

Alligator Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alligator Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alligator Bioscience from 9/13/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Alligator Bioscience pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Alligator Bioscience in the year 2023?

In the year 2023, Alligator Bioscience distributed 0 SEK as dividends.

In which currency does Alligator Bioscience pay out the dividend?

The dividends of Alligator Bioscience are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Alligator Bioscience

Our stock analysis for Alligator Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alligator Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.